Laidlaw downgraded Evoke Pharma (EVOK) to Hold from Buy after QOL Medical announced a deal to acquire Evoke for $11.00 per share in cash at closing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVOK: